טוען...
Glycoprotein IIb/IIIa inhibitors and low‐molecular‐weight heparins: A combined role in coronary interventions?
Management strategies for acute coronary syndromes (ACS) are making increasing use of both low‐molecular‐weight heparins (LMWHs) and glycoprotein (GP) IIb/IIIa inhibitors. To date, however, relatively few studies have assessed the clinical potential of these two classes of agents in combination. The...
שמור ב:
| הוצא לאור ב: | Clin Cardiol |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley Periodicals, Inc.
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654834/ https://ncbi.nlm.nih.gov/pubmed/11286313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960241304 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|